Medicare Enrolled
Dr. Kelly Parling-Lynch, DO
Medical Oncology · Norton Shores, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parling-Lynch from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parling-Lynch?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parling-Lynch
Dr. Kelly Parling-Lynch is a medical oncology specialist in Norton Shores, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Parling-Lynch performed 42,240 Medicare services across 2,007 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parling-Lynch received a total of $17,463 from 82 pharmaceutical and/or device companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parling-Lynch is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in MI
$17,463 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,240
Medicare services
Top 15% in MI for medical oncology
2,007
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,112 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,000 | $1 | $2 |
| Paclitaxel chemotherapy injection | 9,456 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,200 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,752 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,119 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,071 | $8 | $26 |
| Anti-nausea injection (Aloxi/palonosetron) | 990 | $1 | $31 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
670 | $10 | $35 |
| Injection, granisetron hydrochloride, 100 mcg | 520 | $0 | $1 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
509 | $11 | $34 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
333 | $2 | $8 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
322 | $92 | $292 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
288 | $79 | $224 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $94 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
162 | $64 | $133 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
151 | $7 | $23 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
145 | $9 | $32 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
140 | $10 | $38 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
138 | $16 | $57 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
125 | $13 | $46 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
119 | $2 | $4 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
118 | $47 | $142 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
114 | $9 | $26 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
98 | $17 | $43 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
96 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
95 | $21 | $47 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
95 | $70 | $70 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
94 | $23 | $84 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
84 | $7 | $25 |
| Iron level test | 80 | $6 | $22 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
76 | $6 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
72 | $45 | $151 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
71 | $1 | $2 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
67 | $4 | $12 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
55 | $15 | $51 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
52 | $19 | $65 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
49 | $21 | $66 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
46 | $11 | $37 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
42 | $4 | $13 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 37 | $20 | $71 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
36 | $10 | $27 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
34 | $130 | $264 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
32 | $27 | $101 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
29 | $10 | $26 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $29 | $82 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
26 | $11 | $30 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $92 | $180 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
23 | $9 | $31 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
22 | $27 | $83 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
21 | $14 | $55 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
20 | $4 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $109 | $285 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $100 | $222 |
| New patient office visit, complex (60-74 min) | 16 | $154 | $324 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
14 | $6 | $18 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $134 | $304 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
13 | $12 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.4% high complexity
43.8% medium
11.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,463
Total received (2018-2024)
Avg $2,495/year across 7 years
Top 16% in MI for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
904
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,361 (93.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,102 (6.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,363
2023
$2,962
2022
$3,535
2021
$282
2020
$618
2019
$3,388
2018
$3,315
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$274
GlaxoSmithKline, LLC.
$216
Merck Sharp & Dohme LLC
$209
AstraZeneca Pharmaceuticals LP
$186
Daiichi Sankyo Inc.
$182
ABBVIE INC.
$170
E.R. Squibb & Sons, L.L.C.
$169
Celgene Corporation
$169
EMD Serono, Inc.
$151
Janssen Biotech, Inc.
$108
PFIZER INC.
$99
JAZZ PHARMACEUTICALS INC.
$90
Eisai Inc.
$87
Lilly USA, LLC
$82
Novartis Pharmaceuticals Corporation
$80
GENZYME CORPORATION
$78
Incyte Corporation
$76
ARRAY BIOPHARMA INC
$74
Karyopharm Therapeutics Inc.
$67
SpringWorks Therapeutics, Inc.
$66
Regeneron Healthcare Solutions, Inc.
$58
Ipsen Biopharmaceuticals, Inc
$55
PharmaEssentia USA Corporation
$48
Myriad Genetic Laboratories, Inc.
$47
Amneal Pharmaceuticals LLC
$46
Takeda Pharmaceuticals U.S.A., Inc.
$46
Astellas Pharma US Inc
$45
Kite Pharma, Inc.
$45
PUMA BIOTECHNOLOGY, INC.
$36
Acrotech Biopharma Inc.
$36
Deciphera Pharmaceuticals Inc.
$31
SUN PHARMACEUTICAL INDUSTRIES INC.
$30
BeiGene USA, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
SERVIER PHARMACEUTICALS LLC
$25
Agios Pharmaceuticals, Inc.
$24
Aveo Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$20
Rigel Pharmaceuticals, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
Mirati Therapeutics, Inc.
$16
Gilead Sciences, Inc.
$16
Top 3 companies account for 20.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,294
Genentech USA, Inc.
$1,207
Novartis Pharmaceuticals Corporation
$744
E.R. Squibb & Sons, L.L.C.
$696
Janssen Biotech, Inc.
$689
PFIZER INC.
$667
Celgene Corporation
$586
Merck Sharp & Dohme LLC
$551
Ipsen Biopharmaceuticals, Inc
$515
Amgen Inc.
$506
Lilly USA, LLC
$505
Pharmacyclics LLC, An AbbVie Company
$500
GlaxoSmithKline, LLC.
$440
Foundation Medicine, Inc.
$400
Astellas Pharma US Inc
$366
Eisai Inc.
$342
TESARO, Inc.
$337
Gilead Sciences, Inc.
$317
Takeda Pharmaceuticals U.S.A., Inc.
$316
Bayer HealthCare Pharmaceuticals Inc.
$310
Daiichi Sankyo Inc.
$304
EMD Serono, Inc.
$292
Boehringer Ingelheim Pharmaceuticals, Inc.
$268
JAZZ PHARMACEUTICALS INC.
$267
Incyte Corporation
$253
Novocure GmbH
$250
Seattle Genetics, Inc.
$249
Seagen Inc.
$235
ABBVIE INC.
$229
GENZYME CORPORATION
$216
Merck Sharp & Dohme Corporation
$197
Karyopharm Therapeutics Inc.
$193
PharmaEssentia USA Corporation
$176
Kyowa Kirin, Inc.
$149
Agios Pharmaceuticals, Inc.
$144
Exelixis Inc.
$142
Sirtex Medical Inc
$139
Regeneron Healthcare Solutions, Inc.
$133
EISAI INC.
$127
Myovant Sciences Inc.
$126
BeiGene USA, Inc.
$119
AVEO Pharmaceuticals, Inc.
$119
Rigel Pharmaceuticals, Inc.
$111
Pharmacyclics LLC, an AbbVie Company
$111
Kite Pharma, Inc.
$104
Janssen Pharmaceuticals, Inc
$99
Bayer Healthcare Pharmaceuticals Inc.
$91
ARRAY BIOPHARMA INC
$85
Alexion Pharmaceuticals, Inc.
$85
AbbVie, Inc.
$70
PUMA BIOTECHNOLOGY, INC.
$69
SpringWorks Therapeutics, Inc.
$66
Heron Therapeutics, Inc.
$66
Puma Biotechnology, Inc.
$60
Mirati Therapeutics, Inc.
$60
Acrotech Biopharma Inc.
$52
Myriad Genetic Laboratories, Inc.
$47
Amneal Pharmaceuticals LLC
$46
TerSera Therapeutics LLC
$43
SERVIER PHARMACEUTICALS LLC
$40
Taiho Oncology, Inc.
$40
Novo Nordisk Inc
$38
G1 Therapeutics, Inc.
$36
Octapharma USA, Inc.
$33
MorphoSys, US Inc.
$31
Deciphera Pharmaceuticals Inc.
$31
Spectrum Pharmaceuticals Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$30
MACROGENICS, INC.
$28
Clovis Oncology, Inc.
$26
Jazz Pharmaceuticals Inc.
$24
Blueprint Medicines Corporation
$22
TAIHO ONCOLOGY, INC.
$21
Aveo Pharmaceuticals, Inc.
$20
EUSA Pharma (US) LLC
$19
Mylan Institutional Inc.
$19
Epizyme, Inc.,
$18
Sobi, Inc
$17
Alnylam Pharmaceuticals Inc.
$17
AbbVie Inc.
$17
Shire North American Group Inc
$12
ADC Therapeutics America, Inc.
$12
Top 3 companies account for 18.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EXKIVITY · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FULPHILA · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBINYN · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
2
Per 100K population
1.1
County median income
$63,495
Nearest hospital
TRINITY HEALTH MUSKEGON HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parling-Lynch is a mixed practice specialist, with above-average Medicare volume (top 15% in MI), with low-engagement industry engagement in the top 16% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parling-Lynch experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Parling-Lynch performed 18,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parling-Lynch receive payments from pharmaceutical companies?
Yes. Dr. Parling-Lynch received a total of $17,463 from 82 companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parling-Lynch's costs compare to other medical oncologists in Norton Shores?
Dr. Parling-Lynch's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parling-Lynch) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Norton Shores
Browse medical oncologists in Norton Shores ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in MI
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in MI
Which MI medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology